Home » Topics » BioWorld Science

BioWorld Science
RSS

RP-7214: a novel DHODH inhibitor with oral activity in preclinical AML models

Nov. 4, 2019

VCP inhibitors patented by University of Pittsburgh

Nov. 4, 2019

HIV replication inhibitors detailed in ViiV Healthcare patent

Nov. 4, 2019

Erytech announces new milestones in TRYbeCA1 phase III study of eryaspase

Nov. 4, 2019

Enanta Pharmaceuticals identifies compounds for RSV infections

Nov. 4, 2019

University of Illinois discloses FOXM1 inhibitors

Nov. 4, 2019

Oligomannate approved in China for mild to moderate AD

Nov. 4, 2019

Neuropore Therapies divulges PIK3C3 inhibitors

Nov. 4, 2019

Promentis Pharmaceuticals announces update on phase II development of SXC-2023

Nov. 4, 2019

OB-002 significantly reduces both primary and metastatic breast cancer in vivo

Nov. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...